AIMMUNE THERAPEUTICS

aimmune-therapeutics-logo

Aimmune Therapeutics is a company operating in the United States biotechnology industry. Its main focus is in the development of product candidates to combat peanut and other food allergies. The company's therapeutic approach, which is referred to as Characterized Oral Desensitization Immunotherapy, is a system designed to desensitize patients to food allergens using characterized biologic products, defined treatment protocols, and support services.

#SimilarOrganizations #People #Financial #Website #More

AIMMUNE THERAPEUTICS

Social Links:

Industry:
Biotechnology Health Care Pharmaceutical Therapeutics

Founded:
2011-01-01

Address:
Brisbane, California, United States

Country:
United States

Website Url:
http://www.aimmune.com

Total Employee:
251+

Status:
Active

Contact:
+1 650 614 5220

Total Funding:
540 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Tag Manager Content Delivery Network Apache Microsoft Exchange Online Amazon Office 365 Mail


Similar Organizations

abfero-pharmaceuticals-logo

Abfero Pharmaceuticals

Abfero Pharmaceuticals is a clinical stage pharmaceutical company that specializes in healthcare and medical industry.

agile-therapeutics-logo

Agile Therapeutics

Agile Therapeutics is pharmaceutical company developing contraceptive healthcare products for women.

arcutis-biotherapeutics-logo

Arcutis Biotherapeutics

Arcutis Biotherapeutics is a clinical-stage biopharmaceutical company focused on developing medical dermatology for unmet needs.

anchiano-therapeutics-logo

Anchiano Therapeutics

Anchiano is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat cancer.

biotheryx-logo

BioTheryX

BioTheryX is a clinical-stage biopharmaceutical company that focuses on the development of therapies for hematological malignancies.

calidi-biotherapeutics-logo

Calidi Biotherapeutics

Calidi Biotherapeutics is a clinical-stage biotechnology company at the forefront of oncolytic virus-based immunotherapies for cancer.

checkmate-pharmaceuticals-logo

Checkmate Pharmaceuticals

Checkmate Pharma is a clinical stage biopharmaceutical company developing a new approach for cancer immunotherapy.

edgewise-therapeutics-logo

Edgewise Therapeutics

Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.

gritstone-bio-logo

Gritstone Bio

Gritstone Oncology is a clinical-stage biotech company that develops tumor-specific cancer immunotherapies to fight multiple cancer types.

jacobio-pharmaceuticals-logo

Jacobio Pharmaceuticals

Jacobio Pharmaceuticals is a clinical-stage pharmaceutical company focusing on the development of innovative oncology and other therapies.

lixte-biotechnology-holdings-logo

Lixte Biotechnology Holdings

Lixte Biotechnology Holdings, a clinical-stage pharmaceutical company, focuses on discovering drugs for more effective cancer treatments.

ocunexus-therapeutics-logo

Ocunexus Therapeutics

Ocunexus Therapeutics is a biopharmaceutical company that develops therapeutics for unmet clinical needs in ophthalmology.

pinpoint-therapeutics-logo

Pinpoint Therapeutics

Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.

realm-therapeutics-logo

Realm Therapeutics

Realm Tx is a clinical stage biopharmaceutical company passionately committed to leveraging its proprietary immunomodulatory technology

sonnet-biotherapeutics-logo

Sonnet BioTherapeutics

Sonnet BioTherapeutics is a biotechnology company for innovating biologic drugs of the single or bispecific mechanism of action.

windgap-medical-logo

Windgap Medical

WindGap Medical is a biotech company that manufactures medical devices used to treat patients with severe allergies.


Current Advisors List

walter-flamenbaum_image

Walter Flamenbaum Board of Directors @ Aimmune Therapeutics
Board_member

patrick-enright_image

Patrick Enright Member of the Board of Directors @ Aimmune Therapeutics
Board_member

stephen-dilly_image

Stephen Dilly Board of Directors @ Aimmune Therapeutics
Board_member

joon-yun_image

Joon Yun Board of Directors @ Aimmune Therapeutics
Board_member

Current Employees Featured

andrew-oxtoby_image

Andrew Oxtoby
Andrew Oxtoby President & Chief Executive Officer @ Aimmune Therapeutics
President & Chief Executive Officer
2020-10-01

joe-cooper_image

Joe Cooper
Joe Cooper Acting CBO @ Aimmune Therapeutics
Acting CBO

carol-zoltowski_image

Carol Zoltowski
Carol Zoltowski VP Regulatory Affairs @ Aimmune Therapeutics
VP Regulatory Affairs

deniel-adelmam_image

Deniel Adelmam
Deniel Adelmam Head Of Research & Development @ Aimmune Therapeutics
Head Of Research & Development
2020-10-01

mary-rozenman_image

Mary Rozenman
Mary Rozenman SVP, Corporate and Commercial Development @ Aimmune Therapeutics
SVP, Corporate and Commercial Development
2015-04-08

isabelle-dearmond_image

Isabelle DeArmond
Isabelle DeArmond CMO @ Aimmune Therapeutics
CMO

sue-barrowcliffe_image

Sue Barrowcliffe
Sue Barrowcliffe General Manager Europe @ Aimmune Therapeutics
General Manager Europe
2016-01-01

Founder


bryan-walser_image

Bryan Walser

Stock Details


Company's stock symbol is NASDAQ:AIMT

Investors List

nestl-health-science_image

Nestlรฉ Health Science

Nestlรฉ Health Science investment in Post-IPO Equity - Aimmune Therapeutics

nestl-health-science_image

Nestlรฉ Health Science

Nestlรฉ Health Science investment in Post-IPO Equity - Aimmune Therapeutics

nestl-health-science_image

Nestlรฉ Health Science

Nestlรฉ Health Science investment in Post-IPO Equity - Aimmune Therapeutics

foresite-capital_image

Foresite Capital

Foresite Capital investment in Series B - Aimmune Therapeutics

aisling-capital_image

Aisling Capital

Aisling Capital investment in Series B - Aimmune Therapeutics

longitude-capital_image

Longitude Capital

Longitude Capital investment in Series B - Aimmune Therapeutics

adage-capital-management_image

Adage Capital Management

Adage Capital Management investment in Series B - Aimmune Therapeutics

ra-capital-management_image

RA Capital Management

RA Capital Management investment in Series B - Aimmune Therapeutics

fidelity-management-and-research-company_image

Fidelity Management and Research Company

Fidelity Management and Research Company investment in Series B - Aimmune Therapeutics

longitude-capital_image

Longitude Capital

Longitude Capital investment in Series A - Aimmune Therapeutics

Official Site Inspections

http://www.aimmune.com Semrush global rank: 3.64 M Semrush visits lastest month: 3.9 K

  • Host name: ec2-54-177-178-67.us-west-1.compute.amazonaws.com
  • IP address: 54.177.178.67
  • Location: San Jose United States
  • Latitude: 37.3388
  • Longitude: -121.8914
  • Metro Code: 807
  • Timezone: America/Los_Angeles
  • Postal: 95141

Loading ...

More informations about "Aimmune Therapeutics" on Search Engine